More medical news from Reuters Health News
U.S. FDA accepts application for Indivior's new schizophrenia drug
Reuters Health News : December 12, 2017, 12:06 pm
(Reuters) - U.S. Food and Drug Administration (FDA) accepted Indivior's application for its new schizophrenia treatment, the British drugmaker said on Tuesday, boosting hopes of marketing the drug in the country.
Hearing loss may be a risk factor for dementia
Reuters Health News : December 12, 2017, 11:58 am
(Reuters Health) - Older adults who develop hearing loss may more likely to experience dementia and cognitive decline than their counterparts without hearing problems, a research review suggests.
Motorcycle passengers have higher head injury risks
Reuters Health News : December 12, 2017, 7:13 am
Reuters Health - Motorcycle passengers are less likely than drivers to wear helmets, and they are more likely to suffer traumatic brain injuries in crashes, a U.S. study suggests.
EU renews approval for herbicide glyphosate for five years
Reuters Health News : December 12, 2017, 6:43 am
BRUSSELS (Reuters) - The European Commission said on Tuesday it had renewed for five years the license for the weed-killer glyphosate, a key ingredient in Monsanto Co's top-selling Roundup, following a heated debate over whether it causes cancer.
Did Sanofi, WHO ignore warning signals on dengue vaccine?
Reuters Health News : December 12, 2017, 6:28 am
CHICAGO/LONDON (Reuters) - When French drugmaker Sanofi published the results of clinical trials of children given its dengue vaccine two years ago, the overall findings were that it protected against the world's biggest and fastest growing mosquito-borne disease.